Related Experiment Videos
Ethical issues in pharmacoepidemiological research in Belgium
A G Verstraete1, R H Vander Stichele, L H Deliens
1Laboratory of Clinical Biology, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium. alain.verstraete@rug.ac.be
Pharmacoepidemiology and Drug Safety
|May 1, 2002
Summary
Ethical challenges in Belgian pharmacoepidemiology were navigated successfully. Creative solutions met legal and ethical standards, allowing research to proceed despite regulatory gaps.
Area of Science:
- Pharmacovigilance and Drug Safety
- Epidemiology
- Bioethics
Background:
- Pharmacoepidemiological research in Belgium faces unique ethical considerations.
- Navigating regulatory frameworks is crucial for conducting studies on drug use and safety.
Purpose of the Study:
- To illustrate the ethical issues encountered in pharmacoepidemiological research within the Belgian context.
- To demonstrate practical approaches for addressing ethical challenges in drug safety studies.
Main Methods:
- Case study approach detailing three distinct pharmacoepidemiological investigations.
- Studies focused on drug use in euthanasia, cytomegalovirus in organ transplants, and benzodiazepine consumption patterns.
Main Results:
- Ethical committee requirements and data protection laws were met through innovative strategies.
- Methods included integrating data validation with entry, ensuring anonymity in mail surveys, and prompt removal of identifiers.
Conclusions:
- Despite a perceived 'juridical vacuum,' pharmacoepidemiological research in Belgium was not significantly hindered.
- Adaptability and creative problem-solving enable ethical and legal compliance in drug safety research.